Walvax Biotechnology Co., Ltd. (SHE:300142)

Walvax Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 7, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	18,041	19,320	37,601	64,274	89,423	59,516
Market Cap Growth	-21.94%	-48.62%	-41.50%	-28.12%	50.25%	19.33%
Enterprise Value	17,891	18,563	36,117	62,959	88,584	58,587
Last Close Price	11.28	12.07	23.47	40.11	56.05	38.43
PE Ratio	366.35	135.90	89.66	88.21	209.06	59.33
Forward PE	51.86	37.75	42.75	54.68	56.13	42.78
PS Ratio	7.52	6.85	9.14	12.64	25.82	20.25
PB Ratio	1.65	1.68	3.30	5.85	8.94	7.58
P/TBV Ratio	2.05	2.31	4.57	8.15	11.16	9.54
P/FCF Ratio	190.24	39.71	199.74	582.65	-	-
P/OCF Ratio	32.40	18.64	33.16	53.50	126.79	521.18
EV/Sales Ratio	7.46	6.58	8.78	12.38	25.58	19.93
EV/EBITDA Ratio	142.25	47.89	32.22	44.27	95.49	51.04
EV/EBIT Ratio	-	773.04	43.46	53.63	111.82	57.22
EV/FCF Ratio	188.67	38.16	191.86	570.72	-	-
Debt / Equity Ratio	0.03	0.04	0.07	0.04	0.03	0.01
Debt / EBITDA Ratio	2.16	1.19	0.70	0.32	0.34	0.03
Debt / FCF Ratio	2.87	1.01	4.28	4.19	-	-
Asset Turnover	0.17	0.19	0.27	0.35	0.30	0.35
Inventory Turnover	1.08	0.83	0.74	0.72	0.60	1.02
Quick Ratio	2.60	2.63	2.37	2.24	2.07	3.00
Current Ratio	3.52	2.98	2.73	2.55	2.37	3.36
Return on Equity (ROE)	-0.64%	1.52%	4.57%	8.94%	6.74%	17.93%
Return on Assets (ROA)	-1.41%	0.10%	3.36%	5.06%	4.25%	7.68%
Return on Capital (ROIC)	-1.68%	0.12%	4.39%	6.74%	5.44%	9.44%
Return on Capital Employed (ROCE)	-2.70%	0.20%	6.70%	9.90%	7.60%	12.50%
Earnings Yield	0.27%	0.74%	1.11%	1.13%	0.48%	1.69%
FCF Yield	0.53%	2.52%	0.50%	0.17%	-0.45%	-0.49%
Dividend Yield	0.26%	0.08%	0.04%	0.03%	0.05%	0.18%
Payout Ratio	84.55%	28.80%	4.76%	6.88%	19.48%	3.16%
Buyback Yield / Dilution	0.01%	0.06%	0.21%	-1.93%	-0.90%	-1.37%
Total Shareholder Return	0.28%	0.15%	0.26%	-1.91%	-0.85%	-1.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.